The focal nature of Cox-2 expression in ApcMin/+ mouse tumours likely explains the failure to demonstrate elevated Cox-2 mRNA levels or tissue PGE2 levels in whole transgenic ApcMin/+ mouse tumours compared with non-transgenic tissue (Fig. 2I,J). This evidence concerns the gene PTGS2 and neoplasm.